Bone Mets in Prostate Cancer
Ca de prostata. centro america
2012 GU Cancers Symposium San Francisco, CA February 2-4, 2012 Jerry M. Maniate MD, M.Ed, FRCPC Assistant Professor, Department of Medicine University.
Prostate cancer: Role of systemic therapy in high risk and locally advanced disease Robert Dreicer, M.D., M.S., FACP Chair Dept of Solid Tumor Oncology.
Docetaxel +/- zoledronic acid for hormone-naïve prostate cancer: First overall survival results from STAMPEDE & treatment effects within subgroups (NCT00268476)
2012 GU Cancers Symposium
